BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12139944)

  • 1. A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Novicio C; Guarraia D; Dale JK; Straus SE; Fleisher TA
    Clin Immunol; 2002 Jul; 104(1):21-30. PubMed ID: 12139944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The accumulation of B220+ CD4- CD8- (DN) T cells in C3H-lpr/lpr mice is not accelerated by the stimulation of CD8+ T cells or B220+ DN T cells with staphylococcal enterotoxin B and occurs independently of V beta 8+ T cells.
    Giese T; Davidson WF
    Int Immunol; 1995 Aug; 7(8):1213-23. PubMed ID: 7495728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
    Bleesing JJ; Brown MR; Dale JK; Straus SE; Lenardo MJ; Puck JM; Atkinson TP; Fleisher TA
    Clin Immunol; 2001 Sep; 100(3):314-24. PubMed ID: 11513545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
    Sneller MC; Wang J; Dale JK; Strober W; Middelton LA; Choi Y; Fleisher TA; Lim MS; Jaffe ES; Puck JM; Lenardo MJ; Straus SE
    Blood; 1997 Feb; 89(4):1341-8. PubMed ID: 9028957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functionally anergic lpr and gld B220+ T cell receptor (TCR)-alpha/beta+ double-negative T cells express CD28 and respond to costimulation with phorbol myristate acetate and antibodies to CD28 and the TCR.
    Giese T; Allison JP; Davidson WF
    J Immunol; 1993 Jul; 151(2):597-609. PubMed ID: 7687618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Origin of CD4-CD8-B220+ T cells in MRL-lpr/lpr mice. Clues from a T cell receptor beta transgenic mouse.
    Zhou T; Bluethmann H; Eldridge J; Berry K; Mountz JD
    J Immunol; 1993 Apr; 150(8 Pt 1):3651-67. PubMed ID: 7682246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic T helper 2 T cell cytokine abnormalities in autoimmune lymphoproliferative syndrome, a syndrome marked by defective apoptosis and humoral autoimmunity.
    Fuss IJ; Strober W; Dale JK; Fritz S; Pearlstein GR; Puck JM; Lenardo MJ; Straus SE
    J Immunol; 1997 Feb; 158(4):1912-8. PubMed ID: 9029133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human TCR alpha/beta+ CD4-CD8- double-negative T cells in patients with autoimmune lymphoproliferative syndrome express restricted Vbeta TCR diversity and are clonally related to CD8+ T cells.
    Bristeau-Leprince A; Mateo V; Lim A; Magerus-Chatinet A; Solary E; Fischer A; Rieux-Laucat F; Gougeon ML
    J Immunol; 2008 Jul; 181(1):440-8. PubMed ID: 18566410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.
    Aspinall AI; Pinto A; Auer IA; Bridges P; Luider J; Dimnik L; Patel KD; Jorgenson K; Woodman RC
    Blood Cells Mol Dis; 1999; 25(3-4):227-38. PubMed ID: 10575548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An allogeneic microenvironment influences the phenotype of intermediate T-cell receptor cells expanding in MRL-lpr/lpr mice.
    Tsukahara A; Iiai T; Moroda T; Tada T; Suzuki S; Takeda K; Hatakeyama K; Abo T
    Immunology; 1998 Jun; 94(2):149-59. PubMed ID: 9741335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
    Fleisher TA; Straus SE; Bleesing JJ
    Curr Allergy Asthma Rep; 2001 Nov; 1(6):534-40. PubMed ID: 11895618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
    Bleesing JJ; Brown MR; Straus SE; Dale JK; Siegel RM; Johnson M; Lenardo MJ; Puck JM; Fleisher TA
    Blood; 2001 Oct; 98(8):2466-73. PubMed ID: 11588044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y; Ramnath VR; Eaton AS; Chen A; Simon-Stoos KL; Kleiner DE; Erikson J; Puck JM
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In CD8+ T cell-deficient lpr/lpr mice, CD4+B220+ and CD4+B220- T cells replace B220+ double-negative T cells as the predominant populations in enlarged lymph nodes.
    Giese T; Davidson WF
    J Immunol; 1995 May; 154(10):4986-95. PubMed ID: 7537297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for early onset, polyclonal activation of T cell subsets in mice homozygous for lpr.
    Giese T; Davidson WF
    J Immunol; 1992 Nov; 149(9):3097-106. PubMed ID: 1383337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal intraepithelial lymphocyte T cells are resistant to lpr gene-induced T cell abnormalities.
    Aicher WK; Fujihashi K; Taguchi T; McGhee JR; Yamamoto M; Eldridge JH; Gay S; Kiyono H
    Eur J Immunol; 1992 Jan; 22(1):137-45. PubMed ID: 1346108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acceleration of lpr lymphoproliferative and autoimmune disease by transgenic protein kinase CK2 alpha.
    Rifkin IR; Channavajhala PL; Kiefer HL; Carmack AJ; Landesman-Bollag E; Beaudette BC; Jersky B; Salant DJ; Ju ST; Marshak-Rothstein A; Seldin DC
    J Immunol; 1998 Nov; 161(10):5164-70. PubMed ID: 9820486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo.
    Ford MS; Young KJ; Zhang Z; Ohashi PS; Zhang L
    J Exp Med; 2002 Jul; 196(2):261-7. PubMed ID: 12119351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAS-L, IL-10, and double-negative CD4- CD8- TCR alpha/beta+ T cells are reliable markers of autoimmune lymphoproliferative syndrome (ALPS) associated with FAS loss of function.
    Magerus-Chatinet A; Stolzenberg MC; Loffredo MS; Neven B; Schaffner C; Ducrot N; Arkwright PD; Bader-Meunier B; Barbot J; Blanche S; Casanova JL; Debré M; Ferster A; Fieschi C; Florkin B; Galambrun C; Hermine O; Lambotte O; Solary E; Thomas C; Le Deist F; Picard C; Fischer A; Rieux-Laucat F
    Blood; 2009 Mar; 113(13):3027-30. PubMed ID: 19176318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of the T cell receptor repertoire in Lpr mice.
    Herron LR; Eisenberg RA; Roper E; Kakkanaiah VN; Cohen PL; Kotzin BL
    J Immunol; 1993 Oct; 151(7):3450-9. PubMed ID: 8376785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.